References
- Soignet SL, Frankel SR, Douer D, . United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemia. J Clin Oncol 2001;19:3852–3860.
- Ghavamzadeh A, Alimoghaddam K, Rostami S, . Phase II study of single-agent arsenic trioxide for the front-line therapy of acute promyelocytic leukemia. J Clin Oncol 2011;29:2753–2757.
- Powell BL, Moser B, Stock W, . Arsenic trioxide improves event-free and overall survival for adults with acute promyelocytic leukemia: North American Leukemia Intergroup Study C9710. Blood 2010;116:3751–3757.
- Combined tretinoin and arsenic trioxide for patients with newly diagnosed acute promyelocytic leukemia followed by risk-adapted postremission therapy. NCT01404949. Available from: http://clinicaltrials.gov/ct2/show/NCT01404949
- Gupta D, Bagel B, Gujral S, . Parenthood in patients of acute promyelocytic leukemia after treatment with arsenic trioxide: a case series. Leuk Lymphoma 2012;53:2192–2194.
- He W, Greenwell RJ, Brooks DM, . Arsenic exposure in pregnant mice disrupts placental vasculogenesis and causes spontaneous abortion. Toxicol Sci 2007;99:244–253.
- Milton AH, Smith W, Rahman B, . Chronic arsenic exposure and adverse pregnancy outcomes in Bangladesh. Epidemiology 2005;16:82–86.
- Bloom MS, Louis GM, Sundaram R, . Associations between blood metals and fecundity among women residing in New York State. Reprod Toxicol 2011;31:158–163.
- Li P, Zhong Y, Jiang X, . Seminal plasma metals concentration with respect to semen quality. Biol Trace Elem Res 2012 Feb 10. [Epub ahead of print]